Phase 1 Lung Diseases Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd.118 enrolled4 locationsNCT07407933
Recruiting
Phase 1
Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease
Lung Diseases, Interstitial
Maule Stem Cell Research Institute, Inc.50 enrolled1 locationNCT07372989
Completed
Phase 1
A Phase 1 Study of AP02 (Nintedanib Solution for Inhalation) Delivered via the PARI eFlow® Nebulizer System in Healthy Volunteers and Patients with Idiopathic Pulmonary Fibrosis or Progressive Fibrosing Interstitial Lung Disease
Progressive, Fibrosing Interstitial Lung DiseasesIdiopathic Pulmonary Fibrosis
Avalyn Pharma Pty Ltd38 enrolled1 locationACTRN12620001141932